Kieffer W K M, Rennie C S, Gandhe A J
Portsmouth Hospitals NHS Trust, UK.
Ann R Coll Surg Engl. 2013 Jan;95(1):26-8. doi: 10.1308/003588413x13511609954815.
A simple measure to determine one-year mortality following hip fractures has its benefits. Where there is controversy over implant selection, such a scoring system can facilitate the decision-making process. We undertook a retrospective analysis of one-year postoperative mortality of our hip fracture patients and established their admission serum albumin levels to see if there was any correlation between this and one-year mortality. Our results showed one-year mortality was significantly higher (p =0.0049) for those patients with a serum albumin of <35 g/dl. Of the patients with low albumin, we found that there was no statistical significance between one-year mortality and source of admission (p =0.0789). Prefracture serum albumin can be used as a simple predictor of one-year mortality in patients presenting with a fractured neck of femur, thereby aiding operative planning and implant selection with a view to likely survival and possible need for revision.
一种用于确定髋部骨折后一年死亡率的简单方法有其益处。在植入物选择存在争议的情况下,这样的评分系统可以促进决策过程。我们对髋部骨折患者的术后一年死亡率进行了回顾性分析,并确定了他们入院时的血清白蛋白水平,以查看这与一年死亡率之间是否存在任何关联。我们的结果显示,血清白蛋白<35 g/dl的患者一年死亡率显著更高(p = 0.0049)。在白蛋白水平低的患者中,我们发现一年死亡率与入院来源之间无统计学意义(p = 0.0789)。骨折前血清白蛋白可作为股骨颈骨折患者一年死亡率的简单预测指标,从而有助于手术规划和植入物选择,以考虑可能的生存情况以及翻修的可能性。